Dava Home

Sale!
, , , , ,

Clilidax M 50-Cilnidipine & Metoprolol Succinate Tablets

Original price was: ₹80.63.Current price is: ₹24.19.

Clilidax M 50 combines Cilnidipine (a dual calcium channel blocker) and Metoprolol Succinate 50 mg (a beta-1 selective blocker) for effective blood pressure control and improved cardiovascular protection.

Add to Wishlist
Add to Wishlist

Clilidax M 50 is a dual-action antihypertensive medication containing Cilnidipine and Metoprolol Succinate 50 mg. This combination works synergistically to relax blood vessels, reduce heart workload, and provide smoother, longer-lasting blood pressure control.

It is especially beneficial for patients who require combination therapy due to uncontrolled hypertension on monotherapy.

Key Benefits

  • Provides dual-mechanism BP control

  • Cilnidipine relaxes blood vessels by blocking L-type & N-type calcium channels

  • Metoprolol reduces heart rate and cardiac workload

  • Effective for moderate to severe hypertension

  • Helps protect heart and blood vessels

  • Reduces risk of BP fluctuations during stress

Directions for Use

  • Take once daily or as directed by your physician

  • Swallow whole with a glass of water

  • Do not crush or chew extended-release tablets

  • Take at the same time each day

Safety & Precautions

  • May cause dizziness or fatigue—avoid driving initially

  • Monitor blood pressure and heart rate regularly

  • Avoid alcohol

  • Inform doctor about asthma, diabetes, thyroid issues

  • Not recommended during pregnancy or breastfeeding

  • Do not discontinue abruptly (risk of rebound hypertension or tachycardia)

Storage

  • Store below 25°C

  • Keep blister protected from heat and moisture

  • Keep out of reach of children

Weight 0.01 g
Dimensions 4 × 10 × 1 cm
Composition

Cilnidipine
Metoprolol Succinate

Strength

Cilnidipine (typically 10 mg) + Metoprolol Succinate 50 mg

Reviews

There are no reviews yet.

Be the first to review “Clilidax M 50-Cilnidipine & Metoprolol Succinate Tablets”
Scroll to Top